Priothera SAS
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT (NCT05429632) | Priothera SAS | 2022-06-16 |
Track Priothera SAS automatically
Every clearance here is in the API, with alerts when new ones post.